The prescription drug Bextra (valdecoxib) was commonly prescribed for relief of the signs and symptoms of osteoarthritis and adult rheumatoid arthritis. In 2004, Bextra sales totaled $1.29 billion. However, on April 07, 2005, the United States Food and Drug Administration (FDA) requested thatPfizer voluntarily withdraw Bextra from the United States market, stating, “At this time, the Agency has concluded that the overall risk versus benefit profile of Bextra is unfavorable. This conclusion is based on the potential increased risk for serious cardiovascular (CV) adverse events, which appears to be a class effect of non-steroidal anti-inflammatory drugs (NSAIDs) (excluding aspirin), an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme) compared to other NSAIDs, and the fact that Bextra has not been shown to offer any unique advantages over the other available NSAIDs.”
On September 02, 2009, CBS MoneyWatch ran an article titled, “10 Amazing Facts About Pfizer’s $2.3B Bextra Settlement” stating, “In what must be the dumbest act of off-label drug promotion ever, Pfizer once put out a press release touting Bextra as an effective morphine-sparing analgesic after knee surgery. Bextra was not approved for post-surgery pain.” By the way, Thomas Farina, a Pfizer sales manager was convicted for his role in leading the team of rogue drug reps who promoted Bextra for this off-label use and was sentenced to home confinement and electronic monitoring for six months.
If you live in California, have taken Bextra, and developed a serious cardiovascular (CV) adverse event as a result, you should know that attorney and physician Paul J. Molinaro is available to answer your legal questions and help you determine whether you are entitled to compensation from the manufacturer of this drug. You can reach Paul J. Molinaro, M.D. J.D. toll free at (888)MDJDLAW. The initial consultation is also free, and if Paul determines that you have a case, and you decide to hire Paul, he will represent you on a contingent basis.